Pfizer says Covid-19 pill near 90% effective in final analysis. Can this save the Santa rally?
$Pfizer (PFE.US)$ Pfizer on Tuesday said final analysis of its antiviral Covid-19 pill still showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients. (Source CNBC)
recent lab data suggests the drug retains its effectiveness against the fast-spreading omicron variant of the coronavirus.
The test was done in 2 stages, first had 1,200 participants, the second had 1,000 participants.
The U.S. government has already secured 10 million courses of the Pfizer drug for $5.29 billion.
Obviously a lot of us already bought Pfizer in anticipation of this news. But more noteworthy is perhaps the overall effect this may have on the economy.
1.Will the idea that Omicron might be controllable actually speed up rate hike?
2.Are we going to have a celebratory spending spree from consumers in 2022 Q1?
3.Does this ease lockdown fears enough for us to enjoy a sliver of the Santa rally?
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
lailie : No. Because the market has priced in Covid going away a while ago. It’s the fed now that’s concerning with hawkishness and rate hikes coming sooner than later.
Orlagh : It's just institutional selling at year end to harvest tax loss. I expect selling pressure to end before the holidays. First quarter 2022 will be bullish.
Evelynne : $Pfizer (PFE.US)$ soon to read the “paper hands” “weak hand” just hold it will recover” comments
Just saying good luck everyone